Evidence map›Paper›PMID 12429837›Full record

ArticleMolecular biology of the cell2002

pp60Src mediates insulin-stimulated sequestration of the beta(2)-adrenergic receptor: insulin stimulates pp60Src phosphorylation and activation.

Elena Shumay, Xiaosong Song, Hsien-yu Wang, Craig C Malbon

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors.Journal of cardiovascular pharmacology · 2017
    Review
  2. Article
  3. Trafficking of β-Adrenergic Receptors: Implications in Intracellular Receptor Signaling.Progress in molecular biology and translational science · 2015
    Review
  4. Article
  5. Article
  6. Article
  7. Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elena ShumayDepartment of Pharmacology, Diabetes and Metabolic Diseases Research Center-Health Sciences Center, State University of New York at Stony Brook, Stony Brook, New York 11794-8651, USA.
Xiaosong Song
Hsien-yu Wang
Craig C Malbon
State University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin stimulates a rapid phosphorylation and sequestration of the beta(2)-adrenergic receptor. Analysis of the signaling downstream of the insulin receptor with enzyme inhibitors revealed roles for both phosphatidylinositol 3-kinase and pp60Src. Inhibition of Src with PP2, like the inhibition of phosphatidylinositol 3-kinase with LY294002 [2-(4-morpholynyl)-8-phenyl-4H-1-benzopyran-4-one], blocked the activation of Src as well as insulin-stimulated sequestration of the beta(2)-adrenergic receptor. Depletion of Src with antisense morpholinos also suppressed insulin-stimulated receptor sequestration. Src is shown to be phosphorylated/activated in response to insulin in human epidermoid carcinoma A431 cells as well as in mouse 3T3-L1 adipocytes and their derivative 3T3-F422A cells, well-known models of insulin signaling. Inhibition of Src with PP2 blocks the ability of insulin to sequester beta(2)-adrenergic receptors and the translocation of the GLUT4 glucose transporters. Insulin stimulates Src to associate with the beta(2)-adrenergic receptor/AKAP250/protein kinase A/protein kinase C signaling complex. We report a novel positioning of Src, mediating signals from insulin to phosphatidylinositol 3-kinase and to beta(2)-adrenergic receptor trafficking.

Indexed as

Muscle Proteins3T3 CellsAdrenergic beta-AgonistsAnimalsEnzyme ActivationEnzyme InhibitorsGlucose Transporter Type 4HumansInsulinIsoproterenolMiceModels, BiologicalMonosaccharide Transport ProteinsOligonucleotides, AntisensePhosphatidylinositol 3-KinasesPhosphorylationAdrenergic beta-AgonistsEnzyme InhibitorsFYN protein, humanFyn protein, mouseGlucose Transporter Type 4InsulinIsoproterenollyn protein-tyrosine kinaseMonosaccharide Transport ProteinsMuscle ProteinsOligonucleotides, AntisensePhosphatidylinositol 3-KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-fynProto-Oncogene Proteins pp60(c-src)Receptors, Adrenergic, beta-2Recombinant Fusion ProteinsSLC2A4 protein, humanSlc2a4 protein, mousesrc-Family Kinases

Identifiers

PMID12429837
PMCPMC133605
OpenAlexW2160973729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.